Function of circulating TNF in rheumatoid arthritis patients with infliximab: Link to clinical response.

被引：0
|
作者：
Marotte, H
Miossec, P
机构：
[1] Hop Edouard Herriot, INSERM, U 403, Lyon, France
[2] Hop Edouard Herriot, Dept Immunol, Lyon, France
[3] Hop Edouard Herriot, Dept Rheumatol, Lyon, France
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [1] Circulating bioactive TNFalpha in rheumatoid arthritis patients treated with infliximab: Link to clinical response.
    Marotte, H
    Miossec, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S137 - S137
  • [2] Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
    Marotte, H
    Miossec, P
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 1) : S15 - S15
  • [3] Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
    H Marotte
    P Miossec
    Arthritis Res Ther, 5
  • [4] Circulating bioactive TNFalpha in rheumatoid arthritis patients treated with infliximab: Link to clinical response
    Marotte, H
    Miossec, P
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 181 - 182
  • [5] Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
    Hubert Marotte
    Wlodzimierz Maslinski
    Pierre Miossec
    Arthritis Res Ther, 7
  • [6] Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab:: link to clinical response
    Marotte, H
    Maslinski, W
    Miossec, P
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (01) : R149 - R155
  • [7] CIRCULATING AUTOANTIBODIES AS INDICATORS TO PREDICT THE CLINICAL RESPONSE TO INFLIXIMAB IN RHEUMATOID ARTHRITIS
    Lourido, L.
    Ruiz-Romero, C.
    Picchi, F.
    Perez-Pampin, E.
    Regueiro, C.
    Mera-Varela, A.
    Gonzalez, A.
    Hambardzumyan, K.
    Saevarsdottir, S.
    Nilsson, P.
    Blanco, F. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 312 - 312
  • [8] Infliximab plus methotrexate prevents structural damage progression in rheumatoid arthritis patients which was independent of clinical response.
    Keystone, E
    Han, C
    Keenan, GF
    Van der Heidje, D
    Harriman, G
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S81 - S81
  • [9] CIRCULATING CENTROMERE PROTEIN F AUTOANTIBODIES FOR PREDICTING CLINICAL RESPONSE TO INFLIXIMAB IN RHEUMATOID ARTHRITIS
    Lourido, L.
    Ruiz-Romero, C.
    Picchi, F.
    Diz-Rosales, N.
    Vilaboa-Galan, S.
    Fernandez-Lopez, C.
    Pinto Tasende, J. A.
    Perez-Pampin, E.
    Regueiro Exposito, C.
    Mera Varela, A.
    Gonzalez, A.
    Hambardzumyan, K.
    Saevarsdottir, S.
    Nilsson, P.
    Blanco, F. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1399 - 1399
  • [10] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
12345